Karyopharm Therapeutics Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 1 0 0 0 0 2 30 41 108 210 157 146 145
Przychód Δ r/r 0.0% 317.1% -39.0% -40.8% 9.2% -38.4% 942.2% 1790.1% 34.8% 164.3% 94.1% -25.1% -7.0% -0.5%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 94.1% 97.5% 98.4% 96.7% 96.3% 95.9%
EBIT (mln) -10 -16 -34 -76 -119 -111 -131 -180 -189 -172 -98 -142 -130 -119
EBIT Δ r/r 0.0% 54.1% 113.7% 123.4% 57.0% -7.0% 17.9% 37.8% 5.2% -9.2% -42.8% 44.7% -8.9% -7.8%
EBIT (%) -6783.6% -2506.3% -8772.6% -33120.5% -47630.4% -71903.9% -8133.2% -593.0% -462.9% -159.0% -46.8% -90.5% -88.7% -82.2%
Koszty finansowe (mln) 0 -0 -0 0 -1 -1 -2 2 16 27 26 25 24 37
EBITDA (mln) -10 -16 -34 -76 -119 -111 -131 -176 -184 -169 -98 -140 -129 -39
EBITDA(%) -6728.9% -2486.8% -8772.6% -33090.0% -47630.4% -71903.9% -8133.2% -579.8% -449.7% -156.2% -46.6% -89.1% -88.3% -26.6%
Podatek (mln) 0 -0 -0 -0 -1 0 0 0 0 0 0 0 0 0
Zysk Netto (mln) -10 -16 -34 -76 -118 -110 -129 -178 -200 -196 -124 -165 -143 -76
Zysk netto Δ r/r 0.0% 54.1% 113.7% 123.2% 56.0% -7.3% 17.7% 38.3% 11.9% -1.7% -36.8% 33.2% -13.4% -46.6%
Zysk netto (%) -6783.6% -2506.0% -8771.8% -33090.4% -47272.4% -71153.9% -8036.4% -588.1% -488.1% -181.6% -59.1% -105.2% -98.0% -52.6%
EPS -10.27 -6.64 -5.59 -2.43 -3.32 -2.92 -2.81 -3.14 -3.22 -2.72 -1.65 -2.02 -1.25 -0.63
EPS (rozwodnione) -10.27 -6.64 -5.59 -2.43 -3.32 -2.92 -2.81 -3.14 -3.22 -2.72 -1.65 -2.02 -1.25 -0.6
Ilośc akcji (mln) 1 2 6 31 36 38 46 57 62 72 75 82 114 122
Ważona ilośc akcji (mln) 1 2 6 31 36 38 46 57 62 72 75 82 114 127
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD